Feed HALMY
HA

Halma plc

HALMY · OTC

$93.43 -1.45% (-$1.37)
1M -4.37%
Market Cap £13.6B
P/E Ratio 36.07x
Div. Yield 0.69%
ROE 19.41%

Bulios Fair Price

$79.35

15.1% downside

Current Price

$93.43

Undervalued Fair Value Overvalued

According to Bulios Fair Price, HALMY is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
4/9
Valuation
29 /100
Expensive
P/E 36.07x
EV/EBITDA 21.60x
PEG 1.30x
Growth
85 /100
Growing
EPS growth 17.27%
Rev. growth 12.30%
Book val. growth 10.69%
Profitability
69 /100
Strong
Gross margin 0.00%
Net margin 14.42%
FCF margin 15.45%
Quality
76 /100
Excellent
ROIC 12.42%
ROE 19.41%
Asset turnover 0.71x
Debt
91 /100
Low
Debt/Equity 0.42x
Current ratio 2.14x
Net debt/EBITDA 1.15x
Stability
98 /100
Stable
Beta 0.97x
Rev. volatility 3.82%
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about HALMY
Online

About the company

Halma plc is a British multinational technology and engineering company headquartered in Amersham, founded in 1984. The company specializes in providing innovative solutions in the areas of safety, health, and the environment. Halma develops and sells a wide range of products and technologies focused on improving quality of life and protecting health, including devices for air and water quality monitoring, hygiene systems, and medical equipment. The company operates globally, with its products used in industries such as healthcare, environmental protection, and other sectors.

Sector

Industrials

Industry

Conglomerates

CEO

Marc Arthur Ronchetti

Employees

9,625

Headquarters

Amersham

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.